<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02396251</url>
  </required_header>
  <id_info>
    <org_study_id>43VZ1407</org_study_id>
    <nct_id>NCT02396251</nct_id>
  </id_info>
  <brief_title>Evaluation of Efficacy and Safety of Hyaluronic Acid (HA) Product for Cheek Augmentation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Q-Med AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Q-Med AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multi-centre, evaluator-blinded study in subjects undergoing cheek augmentation. The study
      is designed to assess efficacy with regard to aesthetic midface augmentation and safety after
      treatment with HA product.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of responders in midface fullness using photo scale</measure>
    <time_frame>Month 3</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of responders in midface fullness using photo scale</measure>
    <time_frame>Up to 18 months after treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>Up to 18 months after treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Facial Tissue Augmentation</condition>
  <arm_group>
    <arm_group_label>HA experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HA experimental only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HA comparator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HA experimental + HA comparator</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HA experimental</intervention_name>
    <arm_group_label>HA experimental</arm_group_label>
    <arm_group_label>HA comparator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HA comparator</intervention_name>
    <arm_group_label>HA comparator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Provide a signed and dated informed consent to participate in the study including
             release of copyright of images

          -  Man or woman aged 18 years or older

          -  Be willing to abstain from any other facial plastic surgical or cosmetic procedures in
             close proximity to the treated area

        Exclusion Criteria:

          -  Known/previous allergy or hypersensitivity to any injectable HA gel

          -  History of bleeding disorder or treatment with anticoagulants, thrombolytics, or
             inhibitors of platelet aggregation, omega-3, or vitamin E within 2 weeks before
             treatment

          -  Treatment with chemotherapy, immunosuppressive agents, immunomodulatory therapy,
             topical retinoids, systemic or topical corticosteroids within 3 months before
             treatment and systemic retinoids within 6 months before treatment

          -  Previous tissue augmenting therapy or contouring with permanent filler, fat-injection
             or permanent implant placed in the area to be treated

          -  The subject is, in the opinion of the investigator, unlikely to comply with the
             clinical investigational plan or is unsuitable for any other reason
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Q-Med AB</last_name>
    <role>Study Director</role>
    <affiliation>Q-Med AB</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Gothenburg</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2015</study_first_submitted>
  <study_first_submitted_qc>March 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2015</study_first_posted>
  <last_update_submitted>February 7, 2017</last_update_submitted>
  <last_update_submitted_qc>February 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

